Clomipramine

Role

Indications

Reactions

Primary

Depression	19.7%
Drug Use For Unknown Indication	14.7%
Product Used For Unknown Indication	12.2%
Anxiety	10.9%
Schizophrenia	8.4%
Psychotic Disorder	4.2%
Major Depression	3.8%
Blood Cholesterol Increased	2.9%
Constipation	2.9%
Hypertension	2.9%
Obsessive-compulsive Disorder	2.9%
Type 2 Diabetes Mellitus	2.9%
Mood Altered	2.5%
Antidepressant Therapy	1.3%
Diabetes Mellitus	1.3%
Extrapyramidal Disorder	1.3%
Insomnia	1.3%
Narcolepsy	1.3%
Parkinsonism	1.3%
Suicidal Behaviour	1.3%

White Blood Cell Count Increased	13.2%
Serotonin Syndrome	9.4%
Toxicity To Various Agents	7.5%
Weight Increased	7.5%
Angioedema	5.7%
Breast Cancer	5.7%
Memory Impairment	5.7%
Stevens-johnson Syndrome	5.7%
Ventricular Tachycardia	5.7%
Drug Reaction With Eosinophilia And Systemic Symptoms	3.8%
Inappropriate Antidiuretic Hormone Secretion	3.8%
Neonatal Respiratory Distress Syndrome	3.8%
Pulmonary Embolism	3.8%
Rhabdomyolysis	3.8%
Tachypnoea	3.8%
Withdrawal Syndrome	3.8%
Brugada Syndrome	1.9%
Cerebral Haemorrhage	1.9%
Completed Suicide	1.9%
Hyponatraemia	1.9%

Secondary

Depression	15.8%
Product Used For Unknown Indication	14.1%
Schizophrenia	10.1%
Anxiety	9.6%
Hypertension	7.1%
Blood Cholesterol Increased	6.9%
Type 2 Diabetes Mellitus	6.7%
Constipation	6.7%
Obsessive-compulsive Disorder	6.5%
Drug Use For Unknown Indication	5.6%
Bipolar Disorder	2.1%
Bipolar Ii Disorder	1.8%
Major Depression	1.5%
Attention Deficit/hyperactivity Disorder	1.0%
Psychotic Disorder	1.0%
Impulse-control Disorder	0.9%
Completed Suicide	0.8%
Epilepsy	0.7%
Antidepressant Therapy	0.6%
Autism Spectrum Disorder	0.6%

White Blood Cell Count Increased	45.5%
Weight Increased	7.0%
Resting Tremor	4.3%
Urinary Hesitation	4.3%
Overdose	3.7%
Serotonin Syndrome	3.7%
Completed Suicide	3.2%
Pleurothotonus	3.2%
Drug Toxicity	2.7%
Prothrombin Time Shortened	2.7%
Toxicity To Various Agents	2.7%
Tremor	2.7%
Drug Reaction With Eosinophilia And Systemic Symptoms	2.1%
Sinus Bradycardia	2.1%
Weight Decreased	2.1%
Muscle Spasms	1.6%
Nightmare	1.6%
Off Label Use	1.6%
Pulmonary Embolism	1.6%
Respiratory Arrest	1.6%

Concomitant

Product Used For Unknown Indication	28.6%
Depression	13.3%
Obsessive-compulsive Disorder	8.0%
Crohn's Disease	6.6%
Schizophrenia	6.2%
Anxiety	5.5%
Hypertension	5.3%
Bipolar Disorder	5.0%
Drug Use For Unknown Indication	3.4%
Diffuse Large B-cell Lymphoma	2.7%
Type 2 Diabetes Mellitus	2.3%
Pain	2.1%
Epicondylitis	1.8%
Multiple Sclerosis	1.6%
Affective Disorder	1.4%
Constipation	1.4%
Diabetes Mellitus	1.4%
Asthma	1.1%
Erectile Dysfunction	1.1%
Fistula	1.1%

White Blood Cell Count Increased	15.7%
Contusion	11.2%
White Blood Cell Count Decreased	6.7%
Death	5.6%
Drug Ineffective	5.6%
Somnolence	5.6%
Suicidal Ideation	5.6%
Liver Function Test Abnormal	4.5%
Syncope	4.5%
Type 2 Diabetes Mellitus	4.5%
Headache	3.4%
Hyponatraemia	3.4%
Morbid Thoughts	3.4%
Oedema Peripheral	3.4%
Renal Impairment	3.4%
Thrombocytopenia	3.4%
Tremor	3.4%
Breast Cancer	2.2%
Incorrect Dose Administered	2.2%
Incorrect Drug Administration Duration	2.2%

Interacting

Product Used For Unknown Indication	42.2%
Obsessive-compulsive Disorder	16.3%
Bipolar Disorder	14.1%
Personality Disorder	11.9%
Major Depression	7.4%
Abnormal Behaviour	3.7%
Anxiety	1.5%
Somnolence	1.5%
Affect Lability	0.7%
Depression	0.7%